BRAF and lung cancer: Here, we describe a proof‐of‐concept amplitude modulation‐based multiplex dPCR assay capable of detecting 12 single‐nucleotide and insertion/deletion (indel) variants in EGFR, KRAS, BRAF, and ERBB2, 14 gene fusions in ALK, RET, ROS1, and NTRK1, and MET exon 14 skipping present in non‐small cell lung cancer (NSCLC).